IGHE and asthma: Asthma occurs as type I hypersensitivity reactions when antigens bind to the IgE-FcεRI complex and then recruit and activate Syk [23], which is known to involve in regulation of allergic inflammation response [24] and has been recognized as a potential target for the treatment of immune-mediated disorders such as asthma [25].